Finance

Beta
Lists
GUFICBIO:NSE
Gufic BioSciences Ltd
₹372.40
+5.44%
(+19.20) 1D
Jun 12, 3:30:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for GUFICBIO...
Open
₹355.20
High
₹374.90
Low
₹352.60
Mkt. cap
37.35B
Avg. vol.
150.18K
Volume
161.32K
P/E ratio
74.66
52-wk high
₹407.85
52-wk low
₹268.00
EPS
₹4.99
Shares outstanding
77.83M
No. of employees
1K
Open
₹355.20
High
₹374.90
Low
₹352.60
Mkt. cap
37.35B
Avg. vol.
150.18K
Volume
161.32K
P/E ratio
74.66
52-wk high
₹407.85
52-wk low
₹268.00
EPS
₹4.99
Shares outstanding
77.83M
No. of employees
1K
News stories
From sources across the web
About Gufic BioSciences Ltd
CEOJayesh P. Choksi
Employees1.48K
Founded1970
Headquarters-
SectorPharmaceutical industry
Websitegufic.com
Last report
Jun 1, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
2.52B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.24B
2.37B
2.31B
2.52B
Cost of goods sold
1.01B
1.04B
1.01B
1.15B
Cost of revenue
1.01B
1.04B
1.01B
1.15B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
359.97M
374.51M
400.89M
381.45M
Operating expense
973.69M
1.03B
1.05B
973.09M
Total operating expenses
1.98B
2.07B
2.06B
2.12B
Operating income
255.82M
300.73M
252.86M
395.62M
Other non operating income
9.25M
21.16M
7.90M
-11.74M
EBT including unusual items
172.74M
226.04M
177.20M
289.51M
EBT excluding unusual items
172.74M
226.04M
177.20M
289.51M
Income tax expense
42.04M
57.82M
52.97M
70.54M
Effective tax rate
24.34%
25.58%
29.89%
24.37%
Other operating expenses
536.53M
573.19M
573.22M
515.16M
Net income
130.70M
168.24M
124.24M
218.96M
Net profit margin
5.84%
7.10%
5.37%
8.70%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-92.34M
-95.84M
-83.56M
-94.37M
Net interest expenses
-92.34M
-95.84M
-83.56M
-94.37M
Depreciation and amortization charges
77.19M
77.73M
76.92M
76.49M
EBITDA
308.49M
378.19M
286.97M
472.70M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer